{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T04:15:55Z","timestamp":1730261755032,"version":"3.28.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologie"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00117-024-01314-z","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T12:01:57Z","timestamp":1716033717000},"page":"575-581","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiologisch-interventionelle M\u00f6glichkeiten zur Behandlung von neuroendokrinen Tumoren","Radiologically guided interventional therapies for the treatment of neuroendocrine tumors"],"prefix":"10.1007","volume":"64","author":[{"given":"C. G.","family":"Radosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nebelung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. T.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"key":"1314_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00270-004-4082-6","volume":"28","author":"TD Atwell","year":"2005","unstructured":"Atwell\u00a0TD, Charboneau\u00a0JW, Que\u00a0FG et\u00a0al (2005) Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques. Cardiovasc Intervent Radiol 28:409\u2013421","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1314_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072302","author":"M Barat","year":"2020","unstructured":"Barat\u00a0M, Cottereau\u00a0AS, Kedra\u00a0A et\u00a0al (2020) The role of interventional radiology for the treatment of hepatic metastases from neuroendocrine tumor: an updated review. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm9072302","journal-title":"J Clin Med"},{"key":"1314_CR3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00268-002-6629-5","volume":"26","author":"E Berber","year":"2002","unstructured":"Berber\u00a0E, Flesher\u00a0N, Siperstein\u00a0AE (2002) Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 26:985\u2013990","journal-title":"World J Surg"},{"key":"1314_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/MPA.0b013e3181ebb2a5","volume":"39","author":"JP Boudreaux","year":"2010","unstructured":"Boudreaux\u00a0JP, Klimstra\u00a0DS, Hassan\u00a0MM et\u00a0al (2010) The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas 39:753\u2013766","journal-title":"Pancreas"},{"key":"1314_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246368","author":"RL Cazzato","year":"2021","unstructured":"Cazzato\u00a0RL, Hubele\u00a0F, De Marini\u00a0P et\u00a0al (2021) Liver-directed therapy for neuroendocrine metastases: from interventional radiology to nuclear medicine procedures. Cancers. https:\/\/doi.org\/10.3390\/cancers13246368","journal-title":"Cancers"},{"key":"1314_CR6","doi-asserted-by":"publisher","first-page":"101798","DOI":"10.1016\/j.beem.2023.101798","volume":"37","author":"AK Clift","year":"2023","unstructured":"Clift\u00a0AK, Thomas\u00a0R, Frilling\u00a0A (2023) Developments in interventional management of hepatic metastases from neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 37:101798","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1314_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11864-020-00751-x","volume":"21","author":"D D\u2019souza","year":"2020","unstructured":"D\u2019souza\u00a0D, Golzarian\u00a0J, Young\u00a0S (2020) Interventional liver-directed therapy for neuroendocrine metastases: current status and future directions. Curr Treat Options Oncol 21:52","journal-title":"Curr Treat Options Oncol"},{"key":"1314_CR8","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari\u00a0A, Shen\u00a0C, Halperin\u00a0D et\u00a0al (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 3:1335\u20131342","journal-title":"JAMA Oncol"},{"key":"1314_CR9","doi-asserted-by":"publisher","first-page":"R151","DOI":"10.1530\/EJE-14-0630","volume":"172","author":"T de Baere","year":"2015","unstructured":"de Baere\u00a0T, Deschamps\u00a0F, Tselikas\u00a0L et\u00a0al (2015) GEP-NETS update: interventional radiology: role in the treatment of liver metastases from GEP-NETs. Eur J Endocrinol 172:R151\u2013166","journal-title":"Eur J Endocrinol"},{"key":"1314_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1055\/s-2008-1027555","volume":"29","author":"Y Dorffel","year":"2008","unstructured":"Dorffel\u00a0Y, Wermke\u00a0W (2008) Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography. Ultraschall Med 29:506\u2013514","journal-title":"Ultraschall Med"},{"key":"1314_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/MPA.0000000000000030","volume":"43","author":"ES Engelman","year":"2014","unstructured":"Engelman\u00a0ES, Leon-Ferre\u00a0R, Naraev\u00a0BG et\u00a0al (2014) Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a\u00a0single institution. Pancreas 43:219\u2013225","journal-title":"Pancreas"},{"key":"1314_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12020-013-0130-9","volume":"47","author":"F Fiore","year":"2014","unstructured":"Fiore\u00a0F, Del Prete\u00a0M, Franco\u00a0R et\u00a0al (2014) Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors. Endocrine 47:177\u2013182","journal-title":"Endocrine"},{"key":"1314_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.hpb.2018.12.014","volume":"21","author":"A Frilling","year":"2019","unstructured":"Frilling\u00a0A, Clift\u00a0AK, Braat\u00a0A et\u00a0al (2019) Radioembolisation with 90Y microspheres for neuroendocrine liver metastases: an institutional case series, systematic review and meta-analysis. HPB 21:773\u2013783","journal-title":"HPB"},{"key":"1314_CR14","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/S1470-2045(13)70362-0","volume":"15","author":"A Frilling","year":"2014","unstructured":"Frilling\u00a0A, Modlin\u00a0IM, Kidd\u00a0M et\u00a0al (2014) Recommendations for management of patients with neuroendocrine liver metastases. Lancet Oncol 15:e8\u201321","journal-title":"Lancet Oncol"},{"key":"1314_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00261-004-0258-4","volume":"30","author":"A Gillams","year":"2005","unstructured":"Gillams\u00a0A, Cassoni\u00a0A, Conway\u00a0G et\u00a0al (2005) Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience. Abdom Imaging 30:435\u2013441","journal-title":"Abdom Imaging"},{"key":"1314_CR16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s00268-002-6663-3","volume":"26","author":"P Hellman","year":"2002","unstructured":"Hellman\u00a0P, Ladjevardi\u00a0S, Skogseid\u00a0B et\u00a0al (2002) Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg 26:1052\u20131056","journal-title":"World J Surg"},{"key":"1314_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000475526","volume":"105","author":"RJ Hicks","year":"2017","unstructured":"Hicks\u00a0RJ, Kwekkeboom\u00a0DJ, Krenning\u00a0E et\u00a0al (2017) ENETS consensus guidelines for the standards of care in neuroendocrine neoplasia: peptide receptor radionuclide therapy with radiolabeled somatostatin analogues. Neuroendocrinology 105:295\u2013309","journal-title":"Neuroendocrinology"},{"key":"1314_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejrad.2018.01.012","volume":"100","author":"Z Jia","year":"2018","unstructured":"Jia\u00a0Z, Wang\u00a0W (2018) Yttrium-90 radioembolization for unresectable metastatic neuroendocrine liver tumor: a\u00a0systematic review. Eur J Radiol 100:23\u201329","journal-title":"Eur J Radiol"},{"key":"1314_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2967\/jnumed.119.241273","volume":"62","author":"C Lawhn-Heath","year":"2021","unstructured":"Lawhn-Heath\u00a0C, Fidelman\u00a0N, Chee\u00a0B et\u00a0al (2021) Intraarterial peptide receptor radionuclide therapy using (90)Y-DOTATOC for hepatic metastases of neuroendocrine tumors. J\u00a0Nucl Med 62:221\u2013227","journal-title":"J Nucl Med"},{"key":"1314_CR20","doi-asserted-by":"publisher","first-page":"471203","DOI":"10.1155\/2012\/471203","volume":"2012","author":"E Lee","year":"2012","unstructured":"Lee\u00a0E, Leon Pachter\u00a0H, Sarpel\u00a0U (2012) Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors. Int J Hepatol 2012:471203","journal-title":"Int J Hepatol"},{"key":"1314_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.bpg.2005.02.011","volume":"19","author":"D O\u2019toole","year":"2005","unstructured":"O\u2019toole\u00a0D, Ruszniewski\u00a0P (2005) Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours. Best Pract Res Clin Gastroenterol 19:585\u2013594","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1314_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00270-014-1005-z","volume":"38","author":"G Orgera","year":"2015","unstructured":"Orgera\u00a0G, Krokidis\u00a0M, Cappucci\u00a0M et\u00a0al (2015) Current status of Interventional radiology in the management of gastro-entero-pancreatic neuroendocrine tumours (GEP-NETs). Cardiovasc Intervent Radiol 38:13\u201324","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1314_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143415","author":"K Ramdhani","year":"2022","unstructured":"Ramdhani\u00a0K, Braat\u00a0A (2022) The evolving role of radioembolization in the treatment of neuroendocrine liver metastases. Cancers. https:\/\/doi.org\/10.3390\/cancers14143415","journal-title":"Cancers"},{"key":"1314_CR24","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1002\/ijc.30400","volume":"139","author":"M Riihimaki","year":"2016","unstructured":"Riihimaki\u00a0M, Hemminki\u00a0A, Sundquist\u00a0K et\u00a0al (2016) The epidemiology of metastases in neuroendocrine tumors. Int J Cancer 139:2679\u20132686","journal-title":"Int J Cancer"},{"key":"1314_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejrad.2017.02.007","volume":"89","author":"M Ronot","year":"2017","unstructured":"Ronot\u00a0M, Cuccioli\u00a0F, Dioguardi Burgio\u00a0M et\u00a0al (2017) Neuroendocrine liver metastases: Vascular patterns on triple-phase MDCT are indicative of primary tumour location. Eur J Radiol 89:156\u2013162","journal-title":"Eur J Radiol"},{"key":"1314_CR26","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1148\/rg.284075170","volume":"28","author":"MJ Steward","year":"2008","unstructured":"Steward\u00a0MJ, Warbey\u00a0VS, Malhotra\u00a0A et\u00a0al (2008) Neuroendocrine tumors: role of interventional radiology in therapy. Radiographics 28:1131\u20131145","journal-title":"Radiographics"}],"container-title":["Die Radiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-024-01314-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-024-01314-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-024-01314-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T12:03:19Z","timestamp":1730203399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-024-01314-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,18]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1314"],"URL":"https:\/\/doi.org\/10.1007\/s00117-024-01314-z","relation":{},"ISSN":["2731-7048","2731-7056"],"issn-type":[{"type":"print","value":"2731-7048"},{"type":"electronic","value":"2731-7056"}],"subject":[],"published":{"date-parts":[[2024,5,18]]},"assertion":[{"value":"24 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.G.\u00a0Radosa, H.\u00a0Nebelung, F.\u00a0Sch\u00f6n und R.T.\u00a0Hoffmann geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}